OncoNano is Drug Discovery in United States that focus on developer business. Founded in 2014. They cover business area such as developer, pH-activate compound, disease, simple and robust biomarker, an ultra-ph-sensitive drug delivery vehicle, target application, cancer, surgeon, surgery, intraoperative case.
2014
( 10 years old in 2024 )
Developer
-
181 Grand Avenue
Suite 225
Southlake, TX 76092
United States
Private
developerpH-activate compounddiseasesimple and robust biomarkeran ultra-ph-sensitive drug delivery vehicletarget applicationcancersurgeonsurgeryintraoperative case
* We use standard office opening hours in near OncoNano's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OncoNano is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), OncoNano business is focusing on Developer.
OncoNano headquarter office and corporate office address is located in 181 Grand Avenue Suite 225 Southlake, TX 76092 United States.
OncoNano was founded in United States.
In 2024, OncoNano is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OncoNano, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
